Visa to Buy Fraud Defense Platform BioCatch in $2.4 Billion Deal — Update
By Katherine Hamilton
Visa is acquiring BioCatch, a fraud-reduction platform, for $2.4 billion in cash.
Visa is buying the Israeli company from funds advised by Permira, as well as other shareholders, the company said Monday.
BioCatch uses artificial intelligence to detect fraud and distinguish legitimate users from attackers in real time. The company protects 1.8 billion devices and 760 million users globally.
At the end of 2025, BioCatch exceeded $185 million in annual recurring revenue.
Permira first invested in BioCatch in April 2023 and took a majority stake the following year. In May 2024, Permira said its stake acquisition gave BioCatch an enterprise valuation of $1.3 billion.
Visa has been increasing its use of AI to fight fraud through its Visa Vulnerability Agentic Harness platform, a tool designed to help clients identify and fix vulnerabilities to fraud. Visa has spent $13 billion in fraud technology and infrastructure over the past five years.
"BioCatch will help our clients stop fraud before it reaches the point of payment,"said Andrew Torre, Visa's president of value-added services.
The deal is expected to close by the end of Visa's fiscal second quarter of 2027.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
August 03, 2026 11:56 ET (15:56 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States